{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:41:16Z","timestamp":1794004876116,"version":"4.8.0"},"reference-count":277,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.abb.2024.110140","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T10:21:33Z","timestamp":1725618093000},"page":"110140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches"],"prefix":"10.1016","volume":"761","author":[{"given":"Linghua","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhuo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.abb.2024.110140_bib1","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2217\/hep.15.41","article-title":"Mechanisms of doxorubicin resistance in hepatocellular carcinoma","volume":"3","author":"Cox","year":"2016","journal-title":"Hepatic oncology"},{"key":"10.1016\/j.abb.2024.110140_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172818","article-title":"Effects of doxorubicin on the heart: from molecular mechanisms to intervention strategies","volume":"866","author":"Prathumsap","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib4","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ehf2.12616","article-title":"Reactive fibrosis precedes doxorubicin\u2010induced heart failure through sterile inflammation","volume":"7","author":"Tanaka","year":"2020","journal-title":"ESC heart failure"},{"key":"10.1016\/j.abb.2024.110140_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-013-0334-4","article-title":"Doxorubicin induces senescence and impairs function of human cardiac progenitor cells","volume":"108","author":"Piegari","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.abb.2024.110140_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.03.016","article-title":"Doxorubicin targets multiple players: a new view of an old problem","volume":"127","author":"Cappetta","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.abb.2024.110140_bib8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/jphp.12144","article-title":"Doxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"43","key":"10.1016\/j.abb.2024.110140_bib9","doi-asserted-by":"crossref","first-page":"33585","DOI":"10.1074\/jbc.M003890200","article-title":"Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen: role of reactive oxygen and nitrogen species","volume":"275","author":"Kotamraju","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2024.110140_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3389\/fphar.2019.01531","article-title":"Doxorubicin induces endotheliotoxicity and mitochondrial dysfunction via ROS\/eNOS\/NO pathway","volume":"10","author":"He","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12964-023-01077-5","article-title":"Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy","volume":"21","author":"Shi","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"22","key":"10.1016\/j.abb.2024.110140_bib12","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","article-title":"Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.abb.2024.110140_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.abb.2024.110140_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117264","article-title":"Approaches for reducing chemo\/radiation-induced cardiotoxicity by nanoparticles","volume":"244","author":"Li","year":"2024","journal-title":"Environ. Res."},{"key":"10.1016\/j.abb.2024.110140_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.105973","article-title":"The innate immune response in myocarditis","volume":"134","author":"Khawaja","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.abb.2024.110140_bib16","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3390\/jcm9092885","article-title":"Management of cardiac toxicity induced by chemotherapy","volume":"9","author":"Trapani","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.abb.2024.110140_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12410-015-9320-6","article-title":"Myocardial inflammation\u2014are we there yet?","volume":"8","author":"Greulich","year":"2015","journal-title":"Curr Cardiovasc Imaging Rep"},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.36660\/abchf.20230009","article-title":"Myocarditis in Cancer patients: a review of an emerging problem in Cardio-Oncology","volume":"2","author":"Martins","year":"2022","journal-title":"ABC Heart Fail Cardiomyop"},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jjcc.2020.08.004","article-title":"Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT","volume":"77","author":"Kawada","year":"2021","journal-title":"J. Cardiol."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.abb.2024.110140_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fcvm.2019.00025","article-title":"Neutrophils in post-myocardial infarction inflammation: damage vs. resolution?","volume":"6","author":"Puhl","year":"2019","journal-title":"Frontiers in cardiovascular medicine"},{"issue":"Suppl 1","key":"10.1016\/j.abb.2024.110140_bib22","article-title":"Monocytes and macrophages in cardiac injury and repair","volume":"9","author":"Sager","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/cells10010051","article-title":"Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair","volume":"10","author":"Lafuse","year":"2020","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.abb.2024.110140_bib24","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1111\/bph.13613","article-title":"T\u2010cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation","volume":"174","author":"Stephenson","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102383","article-title":"Clinical presentation of cardiac symptoms following treatment with tumor-infiltrating lymphocytes: diagnostic challenges and lessons learned","volume":"9","author":"Borgers","year":"2024","journal-title":"ESMO open"},{"key":"10.1016\/j.abb.2024.110140_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1268675","article-title":"Identification CCL2, CXCR2, S100A9 of the immune-related gene markers and immune infiltration characteristics of inflammatory bowel disease and heart failure via bioinformatics analysis and machine learning","volume":"10","author":"Luo","year":"2023","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","article-title":"The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases","volume":"10","author":"Russo","year":"2014","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.abb.2024.110140_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10741-018-9716-x","article-title":"Role of cytokines and inflammation in heart function during health and disease","volume":"23","author":"Bartekova","year":"2018","journal-title":"Heart Fail. Rev."},{"issue":"10","key":"10.1016\/j.abb.2024.110140_bib29","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.3390\/jcm9103267","article-title":"Complexity of TNF-\u03b1 signaling in heart disease","volume":"9","author":"Rolski","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.abb.2024.110140_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-017-0660-3","article-title":"Role of inflammation in heart failure","volume":"19","author":"Shirazi","year":"2017","journal-title":"Curr. Atherosclerosis Rep."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cyto.2014.12.024","article-title":"The varying faces of IL-6: from cardiac protection to cardiac failure","volume":"74","author":"Fontes","year":"2015","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.hrthm.2018.11.024","article-title":"Arrhythmias in myocarditis: state of the art","volume":"16","author":"Peretto","year":"2019","journal-title":"Heart Rhythm"},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.abb.2024.110140_bib36","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1177\/0193945919833710","article-title":"Understanding and measuring symptom burden in heart failure: a concept analysis","volume":"41","author":"Stockdill","year":"2019","journal-title":"West. J. Nurs. Res."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib37","first-page":"1221","article-title":"Myocardial tissue characterization and fibrosis by imaging","volume":"13","author":"Karamitsos","year":"2020","journal-title":"Cardiovascular Imaging"},{"key":"10.1016\/j.abb.2024.110140_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","article-title":"Fibrosis and heart failure","volume":"19","author":"Segura","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.abb.2024.110140_bib39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yjmcc.2016.01.011","article-title":"Extracellular matrix-mediated cellular communication in the heart","volume":"91","author":"Valiente-Alandi","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.abb.2024.110140_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.621644","article-title":"Bearing my heart: the role of extracellular matrix on cardiac development, homeostasis, and injury response","volume":"8","author":"Silva","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.abb.2024.110140_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108952","article-title":"Redox interactions-induced cardiac toxicity in cancer therapy","volume":"708","author":"Fu","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib42","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/cvr\/cvab161","article-title":"Senescence mechanisms and targets in the heart","volume":"118","author":"Chen","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jjcc.2019.05.002","article-title":"Cellular senescence in cardiac diseases","volume":"74","author":"Shimizu","year":"2019","journal-title":"J. Cardiol."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166642","article-title":"Senescent cardiac fibroblasts: a key role in cardiac fibrosis","volume":"1869","author":"Osorio","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jcmg.2014.12.026","article-title":"RV longitudinal deformation correlates with myocardial fibrosis in patients with end-stage heart failure","volume":"8","author":"Lisi","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.abb.2024.110140_bib46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12012-022-09762-6","article-title":"Cardiac remodelling following cancer therapy: a review","volume":"22","author":"Panpan","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/bcpt.13648","article-title":"Targeting of cancer cell death mechanisms by curcumin: implications to cancer therapy","volume":"129","author":"Yu","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"13","key":"10.1016\/j.abb.2024.110140_bib48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2174\/1389450123666220705123315","article-title":"Redox interactions in chemo\/radiation therapy-induced lung toxicity; mechanisms and therapy perspectives","volume":"23","author":"Lai","year":"2022","journal-title":"Curr. Drug Targets"},{"issue":"11","key":"10.1016\/j.abb.2024.110140_bib49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/fon-2019-0458","article-title":"Molecular avenues in targeted doxorubicin cancer therapy","volume":"16","author":"Roychoudhury","year":"2020","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-4274(01)00329-0","article-title":"Doxorubicin-induced persistent oxidative stress to cardiac myocytes","volume":"121","author":"Zhou","year":"2001","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.20455\/ros.2016.835","article-title":"Doxorubicin redox biology: redox cycling, topoisomerase inhibition, and oxidative stress","volume":"1","author":"Zhu","year":"2016","journal-title":"Reactive oxygen species (Apex, NC)"},{"key":"10.1016\/j.abb.2024.110140_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101394","article-title":"Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: have we been barking up the wrong tree?","volume":"29","author":"Kalyanaraman","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.abb.2024.110140_bib53","article-title":"\u03b2-Caryophyllene confers cardioprotection by scavenging radicals and blocking ferroptosis","author":"Li","year":"2024","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7582730","article-title":"Chemotherapeutic drugs and mitochondrial dysfunction: focus on doxorubicin, trastuzumab, and sunitinib","volume":"2018","author":"Gorini","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib55","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bbamcr.2011.03.002","article-title":"Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death","volume":"1813","author":"Kuznetsov","year":"2011","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"12","key":"10.1016\/j.abb.2024.110140_bib56","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1111\/jcmm.15305","article-title":"Effects of doxorubicin\u2010induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: insights for future interventions","volume":"24","author":"Osataphan","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib57","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3390\/ijms25052667","article-title":"Mitochondrial dysfunction in heart failure: from pathophysiological mechanisms to therapeutic opportunities","volume":"25","author":"Gallo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib58","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/toxsci\/kfw006","article-title":"A PGC-1\u03b1-mediated transcriptional network maintains mitochondrial redox and bioenergetic homeostasis against doxorubicin-induced toxicity in human cardiomyocytes: implementation of TT21C","volume":"150","author":"Yuan","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.abb.2024.110140_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-021-00719-w","article-title":"Low-level laser prevents doxorubicin-induced skeletal muscle atrophy by modulating AMPK\/SIRT1\/PCG-1\u03b1-mediated mitochondrial function, apoptosis and up-regulation of pro-inflammatory responses","volume":"11","author":"Ou","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.abb.2024.110140_bib60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2014.05.017","article-title":"Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1\u03b1 pathway","volume":"737","author":"Guo","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib61","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxres\/tfad007","article-title":"Empagliflozin attenuates doxorubicin-induced cardiotoxicity by activating AMPK\/SIRT-1\/PGC-1\u03b1-mediated mitochondrial biogenesis","volume":"12","author":"Chen","year":"2023","journal-title":"Toxicology Research"},{"key":"10.1016\/j.abb.2024.110140_bib62","first-page":"12","article-title":"Ferruginol restores SIRT1-PGC-1\u03b1-mediated mitochondrial biogenesis and fatty acid oxidation for the treatment of DOX-induced cardiotoxicity [original research]","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib63","article-title":"Cyclovirobuxine D attenuates doxorubicin\u2010induced cardiomyopathy by suppression of oxidative damage and mitochondrial biogenesis impairment","volume":"2015","author":"Guo","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.abb.2024.110140_bib64","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00210-020-01818-0","article-title":"Effect of troxerutin on oxidative stress and expression of genes regulating mitochondrial biogenesis in doxorubicin-induced myocardial injury in rats","volume":"393","author":"Babaei-Kouchaki","year":"2020","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib65","article-title":"Qishen granule protects against doxorubicin\u2010induced cardiotoxicity by coordinating MDM2\u2010p53\u2010mediated mitophagy and mitochondrial biogenesis","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"22","key":"10.1016\/j.abb.2024.110140_bib66","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.18632\/aging.102418","article-title":"PGC1\u03b1 activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades","volume":"11","author":"Liu","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.abb.2024.110140_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108719","article-title":"Mitochondrial DNA in NLRP3 inflammasome activation","volume":"108","author":"Qiu","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.abb.2024.110140_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neulet.2014.10.016","article-title":"Mitochondrial ROS govern the LPS-induced pro-inflammatory response in microglia cells by regulating MAPK and NF-\u03baB pathways","volume":"584","author":"Park","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.abb.2024.110140_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110736","article-title":"Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-\u03b1\/NF-\u03baB\/NLRP3-mediated pyroptosis","volume":"123","author":"Zha","year":"2023","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.abb.2024.110140_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-016-0553-6","article-title":"Extracellular mtDNA activates NF-\u03baB via toll-like receptor 9 and induces cell death in cardiomyocytes","volume":"111","author":"Bliks\u00f8en","year":"2016","journal-title":"Basic Res. Cardiol."},{"issue":"11","key":"10.1016\/j.abb.2024.110140_bib71","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.21037\/jtd.2019.10.26","article-title":"Extracellular mitochondrial DNA promote NLRP3 inflammasome activation and induce acute lung injury through TLR9 and NF-\u03baB","volume":"11","author":"Wu","year":"2019","journal-title":"J. Thorac. Dis."},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib72","first-page":"221","article-title":"Malvidin mitigates sepsis-induced cardiac injury by modulating the TLR4-iNOS-COX-2 inflammatory pathway and the bax\/bcl-2\/cyto-C mitochondrial apoptosis pathway in a p38 MAPK-dependent manner","volume":"37","author":"Zhang","year":"2024","journal-title":"Biomed. Environ. Sci."},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib73","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0192623313482778","article-title":"Sex-related differences in mast cell activity and doxorubicin toxicity: a study in spontaneously hypertensive rats","volume":"42","author":"Zhang","year":"2014","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10787-021-00894-9","article-title":"Cardiac inflammation and fibrosis following chemo\/radiation therapy: mechanisms and therapeutic agents","volume":"30","author":"Yang","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"9","key":"10.1016\/j.abb.2024.110140_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221940","article-title":"Doxorubicin induces trans-differentiation and MMP1 expression in cardiac fibroblasts via cell death-independent pathways","volume":"14","author":"Narikawa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.abb.2024.110140_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101673","article-title":"The mitochondria-targeted antioxidant MitoQ, attenuates exercise-induced mitochondrial DNA damage","volume":"36","author":"Williamson","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.abb.2024.110140_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-021-00518-6","article-title":"Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatment","volume":"22","author":"Sacks","year":"2021","journal-title":"BMC Pharmacology and Toxicology"},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib78","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TA.0000000000000533","article-title":"MitoQ modulates oxidative stress and decreases inflammation following hemorrhage","volume":"78","author":"Powell","year":"2015","journal-title":"J. Trauma Acute Care Surg."},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib79","doi-asserted-by":"crossref","first-page":"G298","DOI":"10.1152\/ajpgi.00135.2019","article-title":"Mitochondria-targeted antioxidant mitoquinone attenuates liver inflammation and fibrosis in cirrhotic rats","volume":"318","author":"Turkseven","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.abb.2024.110140_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110040","article-title":"Kaempferol protects mitochondria and alleviates damages against endotheliotoxicity induced by doxorubicin","volume":"126","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib81","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3390\/molecules26051460","article-title":"Cryptotanshinone ameliorates doxorubicin-induced cardiotoxicity by targeting akt-GSK-3\u03b2-mPTP pathway in vitro","volume":"26","author":"Wang","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.abb.2024.110140_bib82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2017.11.024","article-title":"Cardiac progenitor cells activated by mitochondrial delivery of resveratrol enhance the survival of a doxorubicin-induced cardiomyopathy mouse model via the mitochondrial activation of a damaged myocardium","volume":"269","author":"Abe","year":"2018","journal-title":"J. Contr. Release"},{"issue":"8","key":"10.1016\/j.abb.2024.110140_bib83","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1039\/C8FO00466H","article-title":"Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3\u03b3","volume":"9","author":"He","year":"2018","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22030","article-title":"Curcumin ameliorates doxorubicin\u2010induced cardiotoxicity by abrogation of inflammation, apoptosis, oxidative DNA damage, and protein oxidation in rats","volume":"32","author":"Benzer","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"12","key":"10.1016\/j.abb.2024.110140_bib85","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.freeradbiomed.2009.03.011","article-title":"Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway","volume":"46","author":"Danz","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/cai2.64","article-title":"Resveratrol activation of SIRT1\/MFN2 can improve mitochondria function, alleviating doxorubicin\u2010induced myocardial injury","volume":"2","author":"Zhang","year":"2023","journal-title":"Cancer Innovation"},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib87","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7555\/JBR.36.20220123","article-title":"Pyroptosis is a drug target for prevention of adverse cardiac remodeling: the crosstalk between pyroptosis, apoptosis, and autophagy","volume":"36","author":"Naryzhnaya","year":"2022","journal-title":"Journal of biomedical research"},{"key":"10.1016\/j.abb.2024.110140_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101169","article-title":"A guide to understanding endoplasmic reticulum stress in metabolic disorders","volume":"47","author":"Lemmer","year":"2021","journal-title":"Mol. Metabol."},{"issue":"7","key":"10.1016\/j.abb.2024.110140_bib89","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41569-021-00511-w","article-title":"Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases","volume":"18","author":"Ren","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib90","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2020.03.027","article-title":"Palmitate induces cardiomyocyte death via inositol requiring enzyme-1 (IRE1)-mediated signaling independent of X-box binding protein 1 (XBP1)","volume":"526","author":"Yamamoto","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib91","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1158\/2159-8290.CD-13-0945","article-title":"Epithelial-to-mesenchymal transition activates PERK\u2013eIF2\u03b1 and sensitizes cells to endoplasmic reticulum stress","volume":"4","author":"Feng","year":"2014","journal-title":"Cancer Discov."},{"issue":"20","key":"10.1016\/j.abb.2024.110140_bib92","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1074\/jbc.RA118.002829","article-title":"The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress","volume":"294","author":"Luhr","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib93","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/biof.1780","article-title":"Golgi stress response: a regulatory mechanism of Golgi function","volume":"47","author":"Gao","year":"2021","journal-title":"Biofactors"},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib94","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3390\/cancers12030569","article-title":"ATF4-dependent NRF2 transcriptional regulation promotes antioxidant protection during endoplasmic reticulum stress","volume":"12","author":"Sarcinelli","year":"2020","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.abb.2024.110140_bib95","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1091\/mbc.e13-11-0664","article-title":"Translational and posttranslational regulation of XIAP by eIF2\u03b1 and ATF4 promotes ER stress\u2013induced cell death during the unfolded protein response","volume":"25","author":"Hiramatsu","year":"2014","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib96","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/ijms17030327","article-title":"Endoplasmic reticulum stress and associated ROS","volume":"17","author":"Zeeshan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.abb.2024.110140_bib97","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1111\/jcmm.17560","article-title":"CaMKII orchestrates endoplasmic reticulum stress and apoptosis in doxorubicin\u2010induced cardiotoxicity by regulating the IRE1\u03b1\/XBP1s pathway","volume":"26","author":"Kong","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"12","key":"10.1016\/j.abb.2024.110140_bib98","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3390\/antiox10121897","article-title":"Endoplasmic reticulum stress promotes iNOS\/NO and influences inflammation in the development of doxorubicin-induced cardiomyopathy","volume":"10","author":"Bagchi","year":"2021","journal-title":"Antioxidants"},{"issue":"10","key":"10.1016\/j.abb.2024.110140_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045078","article-title":"ER stress activates NF-\u03baB by integrating functions of basal IKK activity, IRE1 and PERK","volume":"7","author":"Tam","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.abb.2024.110140_bib100","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/bph.13888","article-title":"Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.abb.2024.110140_bib101","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yjmcc.2023.11.007","article-title":"Targeting heat shock protein 47 alleviated doxorubicin-induced cardiotoxicity and remodeling in mice through suppression of the NLRP3 inflammasome","volume":"186","author":"Shi","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.abb.2024.110140_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119039","article-title":"Study of ER stress and apoptotic proteins in the heart and tumor exposed to doxorubicin","volume":"1868","author":"Bagchi","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib103","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCRESAHA.115.307604","article-title":"Chemical endoplasmic reticulum chaperone alleviates doxorubicin-induced cardiac dysfunction","volume":"118","author":"Fu","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib104","doi-asserted-by":"crossref","first-page":"H2169","DOI":"10.1152\/ajpheart.00068.2009","article-title":"Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2","volume":"297","author":"Spallarossa","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.abb.2024.110140_bib105","article-title":"Resolvin D1 attenuates doxorubicin-induced cardiotoxicity by inhibiting inflammation, oxidative and endoplasmic reticulum stress [original research]","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib106","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00204-022-03241-1","article-title":"Sacubitril\/valsartan reduces endoplasmic reticulum stress in a rat model of doxorubicin-induced cardiotoxicity","volume":"96","author":"Kim","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.abb.2024.110140_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.850053","article-title":"Cariporide attenuates doxorubicin-induced cardiotoxicity in rats by inhibiting oxidative stress, inflammation and apoptosis partly through regulation of akt\/GSK-3\u03b2 and Sirt1 signaling pathway [original research]","volume":"13","author":"Liao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib108","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3892\/ijmm.2015.2291","article-title":"Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway","volume":"36","author":"Lou","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.abb.2024.110140_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116179","article-title":"Ononin alleviates endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity by activating SIRT3","volume":"452","author":"Zhang","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"10.1016\/j.abb.2024.110140_bib110","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.3390\/ijms19113658","article-title":"Ginsenoside Rg1 prevents doxorubicin-induced cardiotoxicity through the inhibition of autophagy and endoplasmic reticulum stress in mice","volume":"19","author":"Xu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.06.007","article-title":"Autophagy and cancer therapy cardiotoxicity: from molecular mechanisms to therapeutic opportunities","volume":"1867","author":"Li","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib112","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cardiores.2005.08.014","article-title":"Autophagy in cardiac myocyte homeostasis, aging, and pathology","volume":"68","author":"Terman","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"24","key":"10.1016\/j.abb.2024.110140_bib113","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.lfs.2013.10.013","article-title":"The role of autophagy in doxorubicin-induced cardiotoxicity","volume":"93","author":"Dirks-Naylor","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.abb.2024.110140_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1133423","article-title":"The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity","volume":"14","author":"Gaytan","year":"2023","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/15548627.2016.1247143","article-title":"Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence","volume":"13","author":"Tai","year":"2017","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib116","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BJ20111451","article-title":"Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling","volume":"441","author":"Lee","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.abb.2024.110140_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118833","article-title":"Autophagy alleviates mitochondrial DAMP-induced acute lung injury by inhibiting NLRP3 inflammasome","volume":"265","author":"Peng","year":"2021","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib118","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11897-021-00519-w","article-title":"The interplay between autophagy and senescence in anthracycline cardiotoxicity","volume":"18","author":"Russo","year":"2021","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.abb.2024.110140_bib119","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yjmcc.2019.06.005","article-title":"SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function","volume":"133","author":"Wang","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.abb.2024.110140_bib120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2022.12.082","article-title":"Doxorubicin induces cardiomyocyte death owing to the accumulation of dysfunctional mitochondria by inhibiting the autophagy fusion process","volume":"195","author":"Toda","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"10","key":"10.1016\/j.abb.2024.110140_bib121","doi-asserted-by":"crossref","first-page":"11096","DOI":"10.1096\/fj.201802663R","article-title":"Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy","volume":"33","author":"Catanzaro","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.abb.2024.110140_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104846","article-title":"Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission","volume":"157","author":"Liang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib123","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/med.21733","article-title":"Autophagy and cardiac diseases: therapeutic potential of natural products","volume":"41","author":"Wu","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"9","key":"10.1016\/j.abb.2024.110140_bib124","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41419-019-1901-x","article-title":"miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b\/P53 pathway in doxorubicin-induced cardiotoxicity","volume":"10","author":"Pan","year":"2019","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.abb.2024.110140_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238856","article-title":"Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts","volume":"15","author":"Mancilla","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.108.799700","article-title":"Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway","volume":"119","author":"Zhu","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.abb.2024.110140_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115354","article-title":"SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy","volume":"207","author":"Sun","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.abb.2024.110140_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113888","article-title":"Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1","volume":"175","author":"Sun","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.abb.2024.110140_bib129","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3390\/molecules22101589","article-title":"Aspalathin reverts doxorubicin-induced cardiotoxicity through increased autophagy and decreased expression of p53\/mTOR\/p62 signaling","volume":"22","author":"Johnson","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.21037\/cdt-19-707","article-title":"Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K\/Akt\/mTOR-dependent manner","volume":"10","author":"Yu","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.abb.2024.110140_bib131","first-page":"11","article-title":"Luteolin attenuates doxorubicin-induced cardiotoxicity through promoting mitochondrial autophagy [original research]","author":"Xu","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.abb.2024.110140_bib132","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bcp.2018.02.025","article-title":"Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion","volume":"150","author":"Gu","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.abb.2024.110140_bib133","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/ph14111188","article-title":"Targeting oxidative stress, NLRP3 inflammasome, and autophagy by fraxetin to combat doxorubicin-induced cardiotoxicity","volume":"14","author":"Kabel","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.abb.2024.110140_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154027","article-title":"Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK\/mTOR pathway","volume":"99","author":"Li","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.abb.2024.110140_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105366","article-title":"Scutellarin attenuates doxorubicin-induced oxidative stress, DNA damage, mitochondrial dysfunction, apoptosis and autophagy in H9c2 cells, cardiac fibroblasts and HUVECs","volume":"82","author":"Zhou","year":"2022","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.abb.2024.110140_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114188","article-title":"Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT\/mTOR signaling","volume":"180","author":"Zhang","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.abb.2024.110140_bib137","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2013.11.015","article-title":"Fibroblasts in myocardial infarction: a role in inflammation and repair","volume":"70","author":"Shinde","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.abb.2024.110140_bib138","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.matbio.2021.01.003","article-title":"Autophagy, tissue repair, and fibrosis: a delicate balance","volume":"100","author":"Migneault","year":"2021","journal-title":"Matrix Biol."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib139","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3892\/mmr.2021.11938","article-title":"Hydrogen sulfide ameliorates doxorubicin-induced myocardial fibrosis in rats via the PI3K\/AKT\/mTOR pathway","volume":"23","author":"Nie","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.abb.2024.110140_bib140","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.bbadis.2016.12.021","article-title":"Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis","volume":"1863","author":"Ma","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.abb.2024.110140_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114691","article-title":"Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK\/mTOR pathway","volume":"162","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.abb.2024.110140_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152508","article-title":"Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt\/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity","volume":"441","author":"Lv","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.abb.2024.110140_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116210","article-title":"Differential impact of doxorubicin dose on cell death and autophagy pathways during acute cardiotoxicity","volume":"453","author":"Kawalec","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib144","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/cmi.2014.89","article-title":"NADPH oxidases: an overview from structure to innate immunity-associated pathologies","volume":"12","author":"Panday","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.abb.2024.110140_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102159","article-title":"The role of NADPH oxidases in infectious and inflammatory diseases","volume":"48","author":"Taylor","year":"2021","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.abb.2024.110140_bib146","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0735-1097(03)00471-6","article-title":"Increased myocardial NADPH oxidase activity in human heart failure","volume":"41","author":"Heymes","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"10.1016\/j.abb.2024.110140_bib147","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1111\/bph.13773","article-title":"Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2","volume":"174","author":"McLaughlin","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib148","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbrc.2009.08.085","article-title":"NADPH oxidases participate to doxorubicin-induced cardiac myocyte apoptosis","volume":"388","author":"Gilleron","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.abb.2024.110140_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172490","article-title":"Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress","volume":"859","author":"Lin","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"22","key":"10.1016\/j.abb.2024.110140_bib150","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1158\/0008-5472.CAN-10-2664","article-title":"Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib151","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1038\/s41598-024-57090-2","article-title":"NADPH oxidase 2 mediates cardiac sympathetic denervation and myocyte autophagy, resulting in cardiac atrophy and dysfunction in doxorubicin-induced cardiomyopathy","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2024.110140_bib152","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.freeradbiomed.2018.03.053","article-title":"Up-regulation of NOX1\/NADPH oxidase following drug-induced myocardial injury promotes cardiac dysfunction and fibrosis","volume":"120","author":"Iwata","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib153","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12060-9","article-title":"Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin: possible role in modulating NADPH oxidase\/ROS-mediated NF\u03baB redox signaling cascade","volume":"7","author":"Priya","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib154","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1535370213520112","article-title":"D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NF\u03baB in kidneys of Wistar rats","volume":"239","author":"Rehman","year":"2014","journal-title":"Exp. Biol. Med."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib155","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/10799893.2017.1360350","article-title":"Effect of uric acid on inflammatory COX-2 and ROS pathways in vascular smooth muscle cells","volume":"37","author":"O\u011fuz","year":"2017","journal-title":"J. Recept. Signal Transduction"},{"issue":"8","key":"10.1016\/j.abb.2024.110140_bib156","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1074\/jbc.274.8.5038","article-title":"Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1\/2-mediated induction of cyclooxygenase-2","volume":"274","author":"Adderley","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2024.110140_bib157","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2741\/3243","article-title":"Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance","volume":"14","author":"Tziomalos","year":"2009","journal-title":"Front. Biosci."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib158","doi-asserted-by":"crossref","first-page":"H165","DOI":"10.1152\/ajpheart.00906.2009","article-title":"Role of arachidonic acid, lipoxygenase, and mitochondrial depolarization in reperfusion arrhythmias","volume":"299","author":"Haworth","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib159","doi-asserted-by":"crossref","first-page":"H1091","DOI":"10.1152\/ajpheart.00290.2018","article-title":"Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters the inflammation-resolution program in the myocardium","volume":"315","author":"Jadapalli","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib160","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/15701611113119990124","article-title":"The prostaglandin agonist beraprost aggravates doxorubicin-mediated apoptosis by increasing iNOS expression in cardiomyocytes","volume":"13","author":"Lian","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.abb.2024.110140_bib161","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.0000121354.34067.48","article-title":"Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure","volume":"109","author":"Delgado","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib162","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/13813455.2019.1630652","article-title":"Protective effects of gallic acid on doxorubicin-induced cardiotoxicity; an experimantal study","volume":"127","author":"Ekinci Akdemir","year":"2021","journal-title":"Arch. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib163","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11033-018-4450-y","article-title":"Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-\u03b1","volume":"46","author":"Ma","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.abb.2024.110140_bib164","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/424813","article-title":"Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in rats: impact of oxidative stress, inflammation, and apoptosis","volume":"2015","author":"Kelleni","year":"2015","journal-title":"J. Toxicol."},{"key":"10.1016\/j.abb.2024.110140_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00721","article-title":"The role of necroptosis in cardiovascular disease","volume":"9","author":"Zhe-Wei","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib166","doi-asserted-by":"crossref","first-page":"R577","DOI":"10.1152\/ajpregu.1998.274.3.R577","article-title":"Tumor necrosis factor in the heart","volume":"274","author":"Meldrum","year":"1998","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.abb.2024.110140_bib167","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yjmcc.2022.07.005","article-title":"Current knowledge of pyroptosis in heart diseases","volume":"171","author":"Gao","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib168","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3390\/cells12060867","article-title":"New insights into the role of ferroptosis in cardiovascular diseases","volume":"12","author":"Fratta Pasini","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.abb.2024.110140_bib169","series-title":"Seminars in Cell & Developmental Biology","article-title":"Molecular mechanisms of regulated necrosis","year":"2014"},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib170","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrd.2015.6","article-title":"Regulated necrosis: disease relevance and therapeutic opportunities","volume":"15","author":"Conrad","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib171","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3537471","article-title":"Regulation of tumor progression by programmed necrosis","volume":"2018","author":"Lee","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib172","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s12276-021-00634-7","article-title":"Necroptosis molecular mechanisms: recent findings regarding novel necroptosis regulators","volume":"53","author":"Seo","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib173","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3390\/ijms21041456","article-title":"Mechanisms and therapeutic regulation of pyroptosis in inflammatory diseases and cancer","volume":"21","author":"Zheng","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.abb.2024.110140_bib174","article-title":"Uncoupled pyroptosis and IL-1\u03b2 secretion downstream of inflammasome signaling","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib175","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jacbts.2023.10.009","article-title":"Molecular mechanisms and therapeutic targeting of ferroptosis in doxorubicin-induced cardiotoxicity","volume":"9","author":"Wu","year":"2024","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib176","article-title":"From iron metabolism to ferroptosis: pathologic changes in coronary heart disease","volume":"2022","author":"Fan","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib177","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3390\/ijms22052439","article-title":"DAMPs and RAGE pathophysiology at the acute phase of brain injury: an overview","volume":"22","author":"Balan\u00e7a","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib178","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clinthera.2016.02.028","article-title":"Key role of DAMP in inflammation, cancer, and tissue repair","volume":"38","author":"Pandolfi","year":"2016","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.abb.2024.110140_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110108","article-title":"The emerging role of ferroptosis in inflammation","volume":"127","author":"Sun","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167301","article-title":"Pyroptosis-induced inflammation and tissue damage","volume":"434","author":"Wei","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.abb.2024.110140_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103157","article-title":"Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis","volume":"72","author":"Wu","year":"2024","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.abb.2024.110140_bib182","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.abb.2024.110140_bib183","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.bcp.2006.04.011","article-title":"NF-\u03baB activation by reactive oxygen species: fifteen years later","volume":"72","author":"Gloire","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.abb.2024.110140_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121390","article-title":"Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1\/TLR4\/NLRP3 signaling pathway in mice","volume":"316","author":"Alzokaky","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.abb.2024.110140_bib185","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1007\/s00018-008-8064-8","article-title":"TLR-4, IL-1R and TNF-R signaling to NF-\u03baB: variations on a common theme","volume":"65","author":"Verstrepen","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib186","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.abb.2024.110140_bib187","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00210-019-01624-3","article-title":"Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK\/NF-\u03baB and TGF-\u03b21 pathways","volume":"392","author":"El-Said","year":"2019","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.abb.2024.110140_bib188","article-title":"I-\u03baB kinase-\u03b5 deficiency improves doxorubicin-induced dilated cardiomyopathy by inhibiting the NF-\u03baB pathway [Original Research]","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib189","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00210-023-02620-4","article-title":"Sodium acetate ameliorates doxorubicin-induced cardiac injury via upregulation of Nrf2\/HO-1 signaling and downregulation of NFkB-mediated apoptotic signaling in Wistar rats","volume":"397","author":"Adeyemi","year":"2024","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib190","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.pharep.2018.03.009","article-title":"Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-\u03baB signaling pathways","volume":"70","author":"Imam","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.abb.2024.110140_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111732","article-title":"Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4\/nuclear factor-\u03baB and Wnt\/\u03b2-catenin pathways","volume":"102","author":"El-Ela","year":"2022","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib192","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12012-019-09511-2","article-title":"Micheliolide protects against doxorubicin-induced cardiotoxicity in mice by regulating PI3K\/Akt\/NF-kB signaling pathway","volume":"19","author":"Kalantary-Charvadeh","year":"2019","journal-title":"Cardiovasc. Toxicol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib193","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13046-020-01595-x","article-title":"TFEB-NF-\u03baB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity","volume":"39","author":"Wang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.abb.2024.110140_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110525","article-title":"NF-\u03baB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity","volume":"130","author":"Xu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"20","key":"10.1016\/j.abb.2024.110140_bib195","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012338","article-title":"Targeting extracellular heat shock protein 70 ameliorates doxorubicin\u2010induced heart failure through resolution of toll\u2010like receptor 2\u2013mediated myocardial inflammation","volume":"8","author":"Liu","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib196","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2174\/18756557MTAwsMjA3w","article-title":"Endothelial to mesenchymal transition in the cardiogenesis and cardiovascular diseases","volume":"16","author":"Anbara","year":"2020","journal-title":"Curr. Cardiol. Rev."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib197","article-title":"Roles of TGF\u2010\u03b2 signals in endothelial\u2010mesenchymal transition during cardiac fibrosis","volume":"2011","author":"Yoshimatsu","year":"2011","journal-title":"Int. J. Inflamm."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib198","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00441-011-1222-6","article-title":"Regulation of endothelial cell plasticity by TGF-\u03b2","volume":"347","author":"van Meeteren","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib199","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.abb.2024.110140_bib200","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/cells8080865","article-title":"Calcitriol attenuates doxorubicin-induced cardiac dysfunction and inhibits endothelial-to-mesenchymal transition in mice","volume":"8","author":"Tsai","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib201","doi-asserted-by":"crossref","first-page":"H1091","DOI":"10.1152\/ajpheart.00312.2022","article-title":"Smad3 promotes adverse cardiovascular remodeling and dysfunction in doxorubicin-treated hearts","volume":"323","author":"Cobb","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib202","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13246","article-title":"Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice","volume":"55","author":"Hou","year":"2022","journal-title":"Cell Prolif."},{"issue":"7","key":"10.1016\/j.abb.2024.110140_bib203","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.118.311282","article-title":"Renin-angiotensin system and cardiovascular functions","volume":"38","author":"Wu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.abb.2024.110140_bib204","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.lfs.2016.02.037","article-title":"\u201cAngiotensin II memory\u201d contributes to the development of hypertension and vascular injury via activation of NADPH oxidase","volume":"149","author":"Li","year":"2016","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib205","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/HYPERTENSIONAHA.118.12286","article-title":"Novel Role of T Cells and IL-6 (Interleukin-6) in angiotensin II\u2013induced microvascular dysfunction","volume":"73","author":"Senchenkova","year":"2019","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib206","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/HYPERTENSIONAHA.118.11860","article-title":"Angiotensin II causes biphasic STAT3 activation through TLR4 to initiate cardiac remodeling","volume":"72","author":"Han","year":"2018","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib207","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004965","article-title":"Intracellular angiotensin\u2010II interacts with nuclear angiotensin receptors in cardiac fibroblasts and regulates rna synthesis, cell proliferation, and collagen secretion","volume":"6","author":"Tadevosyan","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.abb.2024.110140_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175780","article-title":"G\u03b1q protein-biased ligand of angiotensin II type 1 receptor mediates myofibroblast differentiation through TGF-\u03b21\/ERK axis in human cardiac fibroblasts","volume":"951","author":"Parichatikanond","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.abb.2024.110140_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175384","article-title":"Sustained AT1R stimulation induces upregulation of growth factors in human cardiac fibroblasts via G\u03b1q\/TGF-\u03b2\/ERK signaling that influences myocyte hypertrophy","volume":"937","author":"Duangrat","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.abb.2024.110140_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2020.102306","article-title":"ANO1 regulates cardiac fibrosis via ATI-mediated MAPK pathway","volume":"92","author":"Tian","year":"2020","journal-title":"Cell Calcium"},{"issue":"17","key":"10.1016\/j.abb.2024.110140_bib211","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.3390\/ijms22179343","article-title":"Discoidin domain receptor 2 regulates AT1R expression in angiotensin II-stimulated cardiac fibroblasts via fibronectin-dependent integrin-\u03b21 signaling","volume":"22","author":"Titus","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.abb.2024.110140_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152955","article-title":"Schizandrin B attenuates angiotensin II induced endothelial to mesenchymal transition in vascular endothelium by suppressing NF-\u03baB activation","volume":"62","author":"You","year":"2019","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib213","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1159\/000484304","article-title":"Kaempferol alleviates angiotensin II-induced cardiac dysfunction and interstitial fibrosis in mice","volume":"43","author":"Liu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib214","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10741-020-09977-1","article-title":"Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system\u2014from molecular mechanisms to therapeutic applications","volume":"27","author":"Sobczuk","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib215","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jaccao.2020.09.007","article-title":"Dual angiotensin receptor-neprilysin inhibition with sacubitril\/valsartan attenuates systolic dysfunction in experimental doxorubicin-induced cardiotoxicity","volume":"2","author":"Boutagy","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib216","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.phrs.2009.05.007","article-title":"Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity","volume":"60","author":"Ibrahim","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.abb.2024.110140_bib217","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.echo.2020.05.021","article-title":"Protective effects of statin and angiotensin receptor blocker in a rat model of doxorubicin- and trastuzumab-induced cardiomyopathy","volume":"33","author":"Cho","year":"2020","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.abb.2024.110140_bib218","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.874852","article-title":"Inhibition of (Pro)renin receptor-mediated oxidative stress alleviates doxorubicin-induced heart failure [original research]","volume":"12","author":"Du","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib219","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00210-019-01624-3","article-title":"Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK\/NF-\u03baB and TGF-\u03b21 pathways","volume":"392","author":"El-Said","year":"2019","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"15","key":"10.1016\/j.abb.2024.110140_bib220","doi-asserted-by":"crossref","first-page":"24548","DOI":"10.18632\/oncotarget.15595","article-title":"Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib221","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cvr\/cvx162","article-title":"Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity","volume":"114","author":"Hullin","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180571","article-title":"Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy","volume":"12","author":"Piotrowska","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.abb.2024.110140_bib223","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3390\/cells10071596","article-title":"Extracellular vesicles in organ fibrosis: mechanisms, therapies, and diagnostics","volume":"10","author":"Brigstock","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.abb.2024.110140_bib224","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1078-0432.CCR-17-2046","article-title":"Extracellular vesicles released by cardiomyocytes in a doxorubicin-induced cardiac injury mouse model contain protein biomarkers of early cardiac injury","volume":"24","author":"Yarana","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.abb.2024.110140_bib225","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.120.050682","article-title":"MicroRNA-21\u2013dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload","volume":"143","author":"Ramanujam","year":"2021","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.abb.2024.110140_bib226","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11468","article-title":"MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat","volume":"7","author":"Piegari","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib227","article-title":"Activation of miR-34a-5p\/Sirt1\/p66shc pathway contributes to doxorubicin-induced cardiotoxicity","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib228","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69038-3","article-title":"Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity","volume":"10","author":"Piegari","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib229","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/molecules27030781","article-title":"Mechanistic basis for the role of phytochemicals in inflammation-associated chronic diseases","volume":"27","author":"Cote","year":"2022","journal-title":"Molecules"},{"issue":"30","key":"10.1016\/j.abb.2024.110140_bib230","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17466","article-title":"Integration of phytochemicals and phytotherapy into cancer precision medicine","volume":"8","author":"Efferth","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.abb.2024.110140_bib231","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.biopha.2018.10.086","article-title":"Phytochemicals and cognitive health: are flavonoids doing the trick?","volume":"109","author":"Bakoyiannis","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.abb.2024.110140_bib232","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3389\/fphar.2019.01614","article-title":"Phytochemicals in cancer treatment: from preclinical studies to clinical practice","volume":"10","author":"Choudhari","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.abb.2024.110140_bib233","article-title":"Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials","author":"Liao","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.abb.2024.110140_bib234","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00408-019-00260-1","article-title":"Self-reported gastrointestinal side effects of antifibrotic drugs in Dutch idiopathic pulmonary fibrosis patients","volume":"197","author":"Proesmans","year":"2019","journal-title":"Lung"},{"issue":"146","key":"10.1016\/j.abb.2024.110140_bib235","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0057-2017","article-title":"Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis","volume":"26","author":"Lancaster","year":"2017","journal-title":"Eur. Respir. Rev."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib236","article-title":"Effect of prolonged-release pirfenidone on renal function in septic acute kidney injury patients","volume":"14","author":"Tolba","year":"2023","journal-title":"J. Pharm. Negat. Results"},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib237","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/2042098615589905","article-title":"Combination use of medicines from two classes of renin\u2013angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function","volume":"6","author":"Esteras","year":"2015","journal-title":"Therapeutic Advances in Drug Safety"},{"issue":"12","key":"10.1016\/j.abb.2024.110140_bib238","first-page":"4151","article-title":"Management of nephrotoxicity of chemotherapy and targeted agents: 2020","volume":"10","author":"Chiruvella","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib239","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4212\/cjhp.v70i2.1641","article-title":"Risk factors for nephrotoxicity associated with cisplatin","volume":"70","author":"Almanric","year":"2017","journal-title":"Can. J. Hosp. Pharm."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib240","first-page":"99","article-title":"Protective effects of alpha-lipoic acid, resveratrol, and apigenin against oxidative damages, histopathological changes, and mortality induced by lung irradiation in rats","volume":"17","author":"Seyedpour","year":"2024","journal-title":"Curr. Rad."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib241","first-page":"57","article-title":"Histopathological evaluation of nanocurcumin for mitigation of radiation- induced small intestine injury","volume":"16","author":"Ghanbarzadeh","year":"2023","journal-title":"Curr. Rad."},{"issue":"12","key":"10.1016\/j.abb.2024.110140_bib242","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4155\/fmc.14.86","article-title":"The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer","volume":"6","author":"Bonner","year":"2014","journal-title":"Future Med. Chem."},{"issue":"8","key":"10.1016\/j.abb.2024.110140_bib243","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1568026623666221014152759","article-title":"Resveratrol in cancer therapy: from stimulation of genomic stability to adjuvant cancer therapy: a comprehensive review","volume":"23","author":"Amini","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.abb.2024.110140_bib244","first-page":"332","article-title":"Effect of nano-curcumin on radiotherapy-induced skin reaction in breast cancer patients: a randomized, triple-blind, placebo-controlled trial","volume":"15","author":"Talakesh","year":"2022","journal-title":"Curr. Rad."},{"issue":"Supplement_M","key":"10.1016\/j.abb.2024.110140_bib245","doi-asserted-by":"crossref","first-page":"M25","DOI":"10.1093\/eurheartj\/suz220","article-title":"Renal function, electrolytes, and congestion monitoring in heart failure","volume":"21","author":"Rossignol","year":"2019","journal-title":"Eur. Heart J. Suppl."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib246","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/annonc\/mdt433","article-title":"Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review","volume":"25","author":"Puts","year":"2014","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib247","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ecc.12124","article-title":"Adherence to oral antineoplastic agents by cancer patients: definition and literature review","volume":"23","author":"Bassan","year":"2014","journal-title":"Eur. J. Cancer Care"},{"issue":"2","key":"10.1016\/j.abb.2024.110140_bib248","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7812\/TPP\/14-241","article-title":"Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations","volume":"19","author":"Bodai","year":"2015","journal-title":"Perm. J."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib249","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/1389200219666180129125436","article-title":"Herbal immunomodulators-a remedial panacea for designing and developing effective drugs and medicines: current scenario and future prospects","volume":"19","author":"Tiwari","year":"2018","journal-title":"Curr. Drug Metabol."},{"issue":"8","key":"10.1016\/j.abb.2024.110140_bib250","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12032-024-02443-0","article-title":"Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations","volume":"41","author":"Saadh","year":"2024","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.abb.2024.110140_bib251","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.metabol.2014.10.027","article-title":"Biomarkers for personalized oncology: recent advances and future challenges","volume":"64","author":"Kalia","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.abb.2024.110140_bib252","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lfs.2017.05.003","article-title":"Polyphenols, autophagy and doxorubicin-induced cardiotoxicity","volume":"180","author":"Shabalala","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.abb.2024.110140_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117177","article-title":"The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds","volume":"178","author":"Bhol","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"22","key":"10.1016\/j.abb.2024.110140_bib254","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1016\/j.biomaterials.2014.03.084","article-title":"Therapeutic use of H2O2-responsive anti-oxidant polymer nanoparticles for doxorubicin-induced cardiomyopathy","volume":"35","author":"Park","year":"2014","journal-title":"Biomaterials"},{"issue":"33","key":"10.1016\/j.abb.2024.110140_bib255","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/aac7dd","article-title":"Nanoformulations of doxorubicin: how far have we come and where do we go from here?","volume":"29","author":"Bori\u0161ev","year":"2018","journal-title":"Nanotechnology"},{"issue":"12","key":"10.1016\/j.abb.2024.110140_bib256","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/14737140.2021.1991316","article-title":"Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy","volume":"21","author":"Sohail","year":"2021","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"5","key":"10.1016\/j.abb.2024.110140_bib257","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7439.1000519","article-title":"Advances in delivery systems for doxorubicin","volume":"9","author":"Zhao","year":"2018","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib258","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ddr.21399","article-title":"RGD peptide\u2010based target drug delivery of doxorubicin nanomedicine","volume":"78","author":"Sun","year":"2017","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.abb.2024.110140_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112911","article-title":"Smart chitosan\u2013folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells","volume":"220","author":"Amiryaghoubi","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib260","article-title":"Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2024.110140_bib261","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.2147\/IJN.S170067","article-title":"A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth","author":"Zhang","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib262","doi-asserted-by":"crossref","DOI":"10.1038\/srep25333","article-title":"Modeling doxorubicin-induced cardiotoxicity in human pluripotent stem cell derived-cardiomyocytes","volume":"6","author":"Maillet","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2024.110140_bib263","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102825","article-title":"EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2","volume":"65","author":"Wang","year":"2023","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.abb.2024.110140_bib264","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3390\/biomedicines10092178","article-title":"Novel therapies for the treatment of cardiac fibrosis following myocardial infarction","volume":"10","author":"Raziyeva","year":"2022","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.abb.2024.110140_bib265","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCRESAHA.122.320496","article-title":"CRISPR modeling and correction of cardiovascular disease","volume":"130","author":"Liu","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.abb.2024.110140_bib266","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3389\/fphar.2019.00635","article-title":"Mesenchymal stem cell therapy for doxorubicin-induced cardiomyopathy: potential mechanisms, governing factors, and implications of the heart stem cell debate","volume":"10","author":"Abushouk","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.abb.2024.110140_bib267","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1177\/0960327119842613","article-title":"Mesenchymal stem cells pretreated with platelet-rich plasma modulate doxorubicin-induced cardiotoxicity","volume":"38","author":"Zaki","year":"2019","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.abb.2024.110140_bib268","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-015-0142-x","article-title":"Comparison of adipose tissue-and bone marrow-derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats","volume":"6","author":"Ammar","year":"2015","journal-title":"Stem Cell Res. Ther."},{"issue":"7","key":"10.1016\/j.abb.2024.110140_bib269","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/jemt.24544","article-title":"Role of mesenchymal stem cells\u2010derived exosomes on inflammation, apoptosis, fibrosis and telocyte modulation in doxorubicin\u2010induced cardiotoxicity: a closer look at the structural level","volume":"87","author":"Imam","year":"2024","journal-title":"Microsc. Res. Tech."},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00395-022-00918-7","article-title":"Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients","volume":"117","author":"Haupt","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.abb.2024.110140_bib271","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2023.102239","article-title":"Alleviation of doxorubicin-induced cardiotoxicity in rat by mesenchymal stem cells and olive leaf extract via MAPK\/TNF-\u03b1 pathway: preclinical, experimental and bioinformatics enrichment study","volume":"85","author":"Ibrahim","year":"2023","journal-title":"Tissue Cell"},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib272","article-title":"Intravenous cardiac stem cell\u2010derived exosomes ameliorate cardiac dysfunction in doxorubicin induced dilated cardiomyopathy","volume":"2015","author":"Vandergriff","year":"2015","journal-title":"Stem Cell. Int."},{"issue":"6","key":"10.1016\/j.abb.2024.110140_bib273","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3727\/096368914X679219","article-title":"Embryonic stem cells and released factors stimulate c-kit+\/FLK-1+ progenitor cells and promote neovascularization in doxorubicin-induced cardiomyopathy","volume":"24","author":"Singla","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.abb.2024.110140_bib274","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11864-019-0672-z","article-title":"Advanced imaging modalities to monitor for cardiotoxicity","volume":"20","author":"Seraphim","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"issue":"8","key":"10.1016\/j.abb.2024.110140_bib275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160224","article-title":"Biomarkers for presymptomatic doxorubicin-induced cardiotoxicity in breast cancer patients","volume":"11","author":"Todorova","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.abb.2024.110140_bib276","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tox.2015.04.009","article-title":"Gene expression profiling identifies the novel role of immunoproteasome in doxorubicin-induced cardiotoxicity","volume":"333","author":"Zhao","year":"2015","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.abb.2024.110140_bib277","first-page":"19","article-title":"The role of cardioprotection in cancer therapy cardiotoxicity: jacc: CardioOncology state-of-the-art review","volume":"4","author":"Omland","year":"2022","journal-title":"Cardio Oncology"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124002625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986124002625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T20:00:49Z","timestamp":1745611249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986124002625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":277,"alternative-id":["S0003986124002625"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2024.110140","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of doxorubicin-induced cardiac inflammation and fibrosis; therapeutic targets and approaches","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2024.110140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110140"}}